Globe Life Inc. (NYSE:GL – Get Free Report) declared a quarterly dividend on Thursday, November 6th. Investors of record on Monday, January 5th will be given a dividend of 0.27 per share on Friday, January 30th. This represents a c) annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Monday, January 5th.
Globe Life has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 20 consecutive years. Globe Life has a payout ratio of 7.2% meaning its dividend is sufficiently covered by earnings. Research analysts expect Globe Life to earn $15.03 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 7.2%.
Globe Life Stock Down 0.7%
Globe Life stock traded down $0.97 during trading on Friday, reaching $130.86. 117,823 shares of the company’s stock were exchanged, compared to its average volume of 631,655. Globe Life has a 52-week low of $100.27 and a 52-week high of $147.83. The firm has a market cap of $10.60 billion, a price-to-earnings ratio of 9.50 and a beta of 0.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. The company’s 50-day moving average is $138.36 and its two-hundred day moving average is $130.29.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on GL shares. BMO Capital Markets reiterated a “market perform” rating and issued a $149.00 price target (up from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Truist Financial boosted their target price on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Wells Fargo & Company reduced their price target on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Globe Life in a research report on Wednesday, October 8th. Finally, Cfra Research upgraded shares of Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $153.56.
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading
- Five stocks we like better than Globe Life
- What Investors Need to Know to Beat the Market
- Netflix Stock Split Explained: What It Means for Investors
- Buy P&G Now, Before It Sets A New All-Time High
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
- Using the MarketBeat Stock Split Calculator
- AI Trade Over? Datadog Results Say It’s Gaining Momentum
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
